EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters

Eduardo Gallardo-Toledo iD, Megan Neary iD, Joanne Sharp iD, Joanne Herriott, Edyta Kijak, Chloe Bramwell iD, Paul Curley, Usman Arshad iD, Henry Pertinez, Rajith K R Rajoli iD, Anthony Valentijn, Helen Cox und 4 weitere

Viruses · 2023

DOI: 10.3390/v15112161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Eduardo Gallardo-Toledo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pibrentasvir (PIB) has been demonstrated to block exonuclease activity of the SARS-CoV-2 polymerase, protecting favipiravir (FVP) and remdesivir (RDV) from post-incorporation excision and eliciting antiviral synergy in vitro. The present study investigated the chemoprophylactic efficacy of PIB, FVP, RDV, FVP with PIB, or RDV with PIB dosed intranasally twice a day, using a Syrian golden hamster contact transmission model. Compared to the saline control, viral RNA levels were significantly lower in throat swabs in FVP (day 7), RDV (day 3, 5, 7), and RDV+PIB (day 3, 5) treatment groups. Similarly, findings were evident for nasal turbinate after PIB and RDV treatment, and lungs after PIB, FVP, and FVP+PIB treatment at day 7. Lung viral RNA levels after RDV and RDV+PIB treatment were only detectable in two animals per group, but the overall difference was not statistically significant. In situ examination of the lungs confirmed SARS-CoV-2 infection in all animals, except for one in each of the RDV and RDV+PIB treatment groups, which tested negative in all virus detection approaches. Overall, prevention of transmission was observed in most animals treated with RDV, while other agents reduced the viral load following contact transmission. No benefit of combining FVP or RDV with PIB was observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19CricetinaeAnimalsMesocricetusLungNucleotidyltransferasesRNA, ViralAntiviral Agents

Stichwörter der Autor:innen

SARS-CoV-2chemoprophylaxisfavipiravirpibrentasvirremdesivir

Substanzen

NucleotidyltransferasesRNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK.
  • Centre of Excellence in Long-Acting Therapeutics (CELT), University of Liverpool, Liverpool L69 3BX, UK.
  • Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK.
  • Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.

ORCID-Profile: Eduardo Gallardo-Toledo, Megan Neary, Joanne Sharp, Chloe Bramwell, Usman Arshad, Rajith K R Rajoli, Lee Tatham, Anja Kipar, James P Stewart, Andrew Owen

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • Swiss National Science Foundation
  • EPSRC
  • NIH
  • MRC
  • BBSRC
  • Innovate UK

Zitieren

APA

Gallardo-Toledo, E., Neary, M., Sharp, J., Herriott, J., Kijak, E., Bramwell, C., Curley, P., Arshad, U., Pertinez, H., Rajoli, R. K. R., Valentijn, A., Cox, H., Tatham, L., Kipar, A., Stewart, J. P., & Owen, A. (2023). Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters. Viruses. https://doi.org/10.3390/v15112161

Vancouver

Gallardo-Toledo E, Neary M, Sharp J, Herriott J, Kijak E, Bramwell C, et al. Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters. Viruses. 2023. doi:10.3390/v15112161

BibTeX
@article{GallardoToledo2023,
  author = {Gallardo-Toledo, Eduardo and Neary, Megan and Sharp, Joanne and Herriott, Joanne and Kijak, Edyta and Bramwell, Chloe and Curley, Paul and Arshad, Usman and Pertinez, Henry and Rajoli, Rajith K R and Valentijn, Anthony and Cox, Helen and Tatham, Lee and Kipar, Anja and Stewart, James P and Owen, Andrew},
  title = {Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15112161}
}
Kostenlos starten →